{"entity":{"id":"jsmo","kind":"institution","name":"Japanese Society of Medical Oncology","aka":["JSMO","日本臨床腫瘍学会"],"tldr":"Japan's medical oncology society, which certifies Japan's medical oncologists, holds a large annual meeting and publishes clinical guidelines with the Japan Society of Clinical Oncology.","summary":"Founded in 2002 from the earlier Japanese Society of Medical Oncology study group, JSMO established medical oncology as a board-certified specialty in Japan and now has more than 10,000 members. Its annual meeting, held in English and Japanese, presents Japanese trial data and hosts joint sessions with ASCO, ESMO and the Korean and Chinese societies, and it publishes guidelines on cancer genomic profiling, molecular testing, febrile neutropenia and antiemetics together with the Japan Society of Clinical Oncology. JSMO has been central to Japan's national programme of comprehensive genomic profiling under public insurance and to the certification of core cancer genomic medicine hospitals.","asOf":"2026-09-09","links":[{"label":"JSMO","url":"https://www.jsmo.or.jp"}],"tags":[],"related":["jsmo-jsco-guidelines"],"cancers":[],"sections":["targeted-therapy"],"technologies":["cgp","companion-diagnostic"],"targets":[],"drugs":[],"companies":["jcog","wjog"],"institutions":["ncc-japan","jfcr","pmda","asco","esmo"],"pathways":[],"terms":[],"trials":[],"people":["yoshino-takayuki","ohe-yuichiro","hidetoshi-hayashi"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Tokyo","country":"JP","lat":35.69,"lng":139.7,"institutionType":"consortium","website":"https://www.jsmo.or.jp","programs":["Board certification of medical oncologists","JSMO Annual Meeting","Clinical guidelines (with JSCO)","Cancer genomic medicine policy"]},"route":"/institutions/jsmo/","neighbours":{"collection":[{"id":"jsmo-jsco-guidelines","kind":"collection","name":"Japanese oncology guidelines (JSMO, JSCO and organ societies)","route":"/collections/jsmo-jsco-guidelines/"}],"section":[{"id":"targeted-therapy","kind":"section","name":"Targeted Therapy","route":"/fronts/targeted-therapy/"}],"technology":[{"id":"companion-diagnostic","kind":"technology","name":"Companion diagnostics","route":"/technologies/companion-diagnostic/"},{"id":"cgp","kind":"technology","name":"Comprehensive genomic profiling","route":"/technologies/cgp/"}],"company":[{"id":"jcog","kind":"company","name":"Japan Clinical Oncology Group (JCOG)","route":"/companies/jcog/"},{"id":"wjog","kind":"company","name":"West Japan Oncology Group","route":"/companies/wjog/"}],"institution":[{"id":"asco","kind":"institution","name":"American Society of Clinical Oncology (ASCO)","route":"/institutions/asco/"},{"id":"jfcr","kind":"institution","name":"Cancer Institute Hospital of JFCR","route":"/institutions/jfcr/"},{"id":"esmo","kind":"institution","name":"European Society for Medical Oncology (ESMO)","route":"/institutions/esmo/"},{"id":"ncc-japan","kind":"institution","name":"National Cancer Center Hospital","route":"/institutions/ncc-japan/"},{"id":"pmda","kind":"institution","name":"Pharmaceuticals and Medical Devices Agency","route":"/institutions/pmda/"}],"person":[{"id":"hidetoshi-hayashi","kind":"person","name":"Hidetoshi Hayashi","route":"/people/hidetoshi-hayashi/"},{"id":"yoshino-takayuki","kind":"person","name":"Takayuki Yoshino","route":"/people/yoshino-takayuki/"},{"id":"ohe-yuichiro","kind":"person","name":"Yuichiro Ohe","route":"/people/ohe-yuichiro/"}]}}